MB Growth Partners

MB Growth Partners is an investment fund focused on identifying and supporting growing businesses in New England. Established in 1992, it has been active in providing private capital for over a decade, investing between $500,000 and $5 million in various ventures. The firm emphasizes opportunities in the technology sector, aiming to foster innovation and growth in this area. Additionally, MB Venture Partners, a related entity founded in 2001 and based in Memphis, Tennessee, specializes in early-stage investments in the life sciences sector, particularly in medical devices and biotechnology. This firm seeks to capitalize on product solutions for musculoskeletal diseases and leverages extensive experience and relationships in the industry to guide its investments.

Larry Papasan

Venture Partner

Gary Stevenson

Co-Founder and Managing Partner

Past deals in Tennessee

SweetBio

Seed Round in 2018
SweetBio, Inc. is a medical device company based in Memphis, Tennessee, that focuses on the research, development, and manufacturing of innovative wound care solutions. Established in 2015, the company specializes in creating membranes that utilize medical-grade Manuka honey to enhance healing and reduce complications associated with various wounds, including surgical and diabetic ulcers. SweetBio’s flagship product, Apis, is a patented wound care patch that incorporates Manuka honey at a molecular level with gelatin and nanoparticles, resulting in a solid and long-lasting application that effectively manages exudate and maintains a moist wound environment. This product received FDA clearance in May 2019. SweetBio has participated in prominent accelerator programs and has gained recognition through media features, demonstrating its commitment to advancing wound care treatments.

Cast21

Seed Round in 2017
Cast21 specializes in developing innovative orthopedic medical products, focusing on a lightweight, waterproof, and breathable cast designed for fracture and joint care. Their unique lattice-structure design addresses several limitations of traditional casts, providing comfort and convenience for patients. The cast's breathable material allows for skin care, enabling wearers to wash and scratch the skin beneath the cast while promoting healing. Additionally, Cast21's design incorporates the potential for electronic therapies, which can further reduce healing time. Overall, the company's products aim to enhance the recovery experience for patients by combining functionality with user comfort.

SweetBio

Pre Seed Round in 2015
SweetBio, Inc. is a medical device company based in Memphis, Tennessee, that focuses on the research, development, and manufacturing of innovative wound care solutions. Established in 2015, the company specializes in creating membranes that utilize medical-grade Manuka honey to enhance healing and reduce complications associated with various wounds, including surgical and diabetic ulcers. SweetBio’s flagship product, Apis, is a patented wound care patch that incorporates Manuka honey at a molecular level with gelatin and nanoparticles, resulting in a solid and long-lasting application that effectively manages exudate and maintains a moist wound environment. This product received FDA clearance in May 2019. SweetBio has participated in prominent accelerator programs and has gained recognition through media features, demonstrating its commitment to advancing wound care treatments.

Restore Medical Solutions

Series A in 2015
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

EndoInSight

Seed Round in 2014
EndoInSight specializes in developing a disposable insufflation system aimed at alleviating the pain and discomfort associated with colonoscopy procedures used for colorectal cancer screening. The company utilizes carbon dioxide for colon inflation, a method that significantly reduces post-procedural discomfort compared to traditional air insufflation. Despite the known advantages of using CO2, its adoption in clinical settings has been limited due to low awareness and the high costs of existing insufflation systems. By offering a cost-effective solution, EndoInSight seeks to enhance patient comfort and improve overall outcomes in colorectal cancer treatment.

CrossRoads Extremity Systems

Venture Round in 2014
CrossRoads Extremity Systems, LLC is a medical device company based in Memphis, Tennessee, that specializes in the design, manufacture, and marketing of implant systems specifically for foot and ankle surgeries. Founded in 2014, the company offers a range of products, including the MotoBAND CP Plating System for midfoot and forefoot procedures, STRoPP implant kits, and the MotoCLIP, which aids in bone healing through innovative fixation techniques. Additionally, CrossRoads provides implants like the CrossTIE series for hammertoe correction and revision cases, as well as Allograft wedges and DBM putties. Their DynaFORCE hybrid fixation system enhances surgical flexibility and dynamic compression. The company also emphasizes sustainability through its EcoSMART instrument recovery service, which addresses waste in surgical environments. Products are distributed across the United States, aiming to improve surgical outcomes and operational efficiency in healthcare settings.

EcoSurg

Seed Round in 2014
EcoSurg is a developer of environmentally-friendly surgical supplies aimed at minimizing the carbon footprint in surgical settings. The company’s primary product, the EcoSurg line of patient positioners, consists of disposable foam shapes designed for use in over 20 million surgical procedures annually in the United States. These positioners help ensure patient safety, comfort, and proper access to surgical sites. Traditional disposable positioners are made from petroleum-based materials, which pose environmental hazards and lead to increased disposal costs. EcoSurg's innovative approach seeks to address these concerns by providing sustainable alternatives that reduce environmental impact while maintaining the necessary functionality for surgical procedures.

Blood Monitoring Solutions

Seed Round in 2014
Blood Monitoring Solutions, Inc. is dedicated to advancing blood transfusion safety by providing innovative monitoring systems designed to prevent blood wastage. Based in Memphis, Tennessee, the company has developed a smart blood transport system that allows blood banks to continuously monitor the temperature and condition of each blood unit. This proactive, data-driven approach not only enhances patient safety but also helps reduce costs for hospitals globally. By ensuring that blood is stored within the appropriate temperature range, Blood Monitoring Solutions enables healthcare facilities to preserve blood for extended periods, thereby improving the efficiency of blood utilization and minimizing waste.

Innometrix

Seed Round in 2014
Innometrix, Inc. is a Memphis-based company focused on developing advanced technology to enhance the diagnosis and treatment of female pelvic floor disorders. These conditions are prevalent, affecting approximately 50% of women who have given birth, and they contribute to significant healthcare costs. Innometrix aims to translate biomechanics into clinical solutions by producing a biomechanical snapshot of the female pelvic floor, providing physicians with vital data prior to surgical procedures. The company addresses the limitations of current treatment methods, which often rely on subjective judgment and have high complication rates. By creating innovative device solutions, Innometrix seeks to improve treatment outcomes and increase patient satisfaction in a field that requires significant advancements.

Compression Kinetics

Seed Round in 2014
Compression Kinetics, Inc. is a Memphis-based company specializing in the design and development of innovative medical devices, particularly dynamic compression sleeves. These sleeves utilize shape memory alloy technology to generate pressure waves that enhance circulation, reduce peripheral edema, and help prevent blood clots. By translating clinically proven compression therapy into a sleek and mobile format, Compression Kinetics is positioned to make a significant impact in the $11 billion athletic compression apparel market. The company's products aim to improve recovery times and athletic performance for users, making advanced compression therapy accessible to both amateur and professional athletes.

CamPlex

Seed Round in 2014
CamPlex, founded in 2012 and headquartered in Germantown, Tennessee, operates in the healthcare sector as a manufacturer of high-quality fiber optic solutions. The company specializes in fiber optic-based camera adapter systems and broadcast-grade interface gear. These products are designed to enhance performance and extend signal transmission capabilities, thereby facilitating easier and more efficient signal delivery for broadcast professionals. By providing these innovative solutions, CamPlex helps reduce operating costs by minimizing the need for additional components and expensive replacements.

Tidal Wave Technology

Seed Round in 2014
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Hubble Telemedical

Series A in 2014
Hubble Telemedical focuses on the early detection of systemic and debilitating diseases that can be identified through retinal examination. Their Telemedical Retinal Image Analysis and Diagnosis (TRIAD) technology offers real-time diagnosis of diabetic retinopathy and other retinal conditions, utilizing commonly available retina cameras. This innovative approach addresses the issue of many at-risk individuals not receiving necessary annual retinal exams due to accessibility and convenience challenges. By partnering with healthcare providers, insurance companies, and employers, Hubble Telemedical aims to make retinal screening more accessible, ultimately improving health outcomes and reducing healthcare costs. Their services are fully compliant with HIPAA regulations, ensuring security and ease of use. Clinical studies support the effectiveness of their technology in increasing annual screening compliance, thereby enhancing patient care and facilitating timely treatment for various diseases.

Restore Medical Solutions

Series A in 2014
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Mobilizer

Seed Round in 2014
Mobilizer Inc. has developed an innovative six-wheeled holster designed to facilitate medical ambulation for critical care patients. Modeled after a wheeled walker, this holster features shelves and attachments that allow healthcare providers to easily transport necessary medical equipment, thereby enhancing patient well-being and improving operational efficiency within hospitals. The company emerged from the ZeroTo510 medical device startup accelerator, focusing on solutions that streamline the process of moving patients while ensuring that essential tools are readily accessible.

Hapten Sciences

Venture Round in 2014
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. is a Memphis-based medical device company that specializes in developing vision screening equipment for children. The company employs a patented photoscreening technology, which allows for the rapid and effective detection of various common vision problems in infants, preschool, and school-age children. This non-invasive method screens for issues such as refractive errors, eye alignment problems, and other conditions that could lead to serious vision impairments if not identified early. iScreen Vision's digital photoscreening requires no response from the patient, making it particularly suitable for non-verbal and developmentally challenged children. The company also integrates cloud-based technology to facilitate the storage and analysis of screening images, enabling seamless integration with physicians' electronic medical records. Founded in 2009, iScreen Vision aims to improve early diagnosis and treatment options to prevent irreversible vision loss in children.

Mobilizer

Seed Round in 2013
Mobilizer Inc. has developed an innovative six-wheeled holster designed to facilitate medical ambulation for critical care patients. Modeled after a wheeled walker, this holster features shelves and attachments that allow healthcare providers to easily transport necessary medical equipment, thereby enhancing patient well-being and improving operational efficiency within hospitals. The company emerged from the ZeroTo510 medical device startup accelerator, focusing on solutions that streamline the process of moving patients while ensuring that essential tools are readily accessible.

Focal Point Pharmaceuticals

Seed Round in 2013
Focal Point Pharmaceuticals is a healthcare company focused on pharmaceutical businesses. It was incorporated in 2013 and is based in Memphis, Tennessee, United States.

iScreen Vision

Series B in 2013
iScreen Vision, Inc. is a Memphis-based medical device company that specializes in developing vision screening equipment for children. The company employs a patented photoscreening technology, which allows for the rapid and effective detection of various common vision problems in infants, preschool, and school-age children. This non-invasive method screens for issues such as refractive errors, eye alignment problems, and other conditions that could lead to serious vision impairments if not identified early. iScreen Vision's digital photoscreening requires no response from the patient, making it particularly suitable for non-verbal and developmentally challenged children. The company also integrates cloud-based technology to facilitate the storage and analysis of screening images, enabling seamless integration with physicians' electronic medical records. Founded in 2009, iScreen Vision aims to improve early diagnosis and treatment options to prevent irreversible vision loss in children.

View Medical

Seed Round in 2013
View Medical, Inc. specializes in surgical lighting solutions aimed at enhancing visibility during deep cavity surgeries. Founded in 2013 and based in Memphis, Tennessee, the company has developed the SurgiLight lighting system, which connects to existing overhead surgical lights. This innovative system features a long, flexible cable that allows surgeons to direct bright, localized LED illumination onto the surgical site from various angles. By addressing the common issue of insufficient lighting in operating rooms, View Medical's product aims to reduce the risks associated with surgical errors, which cost the U.S. healthcare system approximately $1.5 billion annually. The SurgiLight offers a practical alternative to traditional surgical headlights, helping to improve operating conditions and ultimately enhance patient outcomes.

BioNanovations

Seed Round in 2013
Bell BioNanonostics Corp. focuses on monitoring of bacterial infection. Bell BioNanonostics Corp. is based in the United States.

EcoSurg

Seed Round in 2013
EcoSurg is a developer of environmentally-friendly surgical supplies aimed at minimizing the carbon footprint in surgical settings. The company’s primary product, the EcoSurg line of patient positioners, consists of disposable foam shapes designed for use in over 20 million surgical procedures annually in the United States. These positioners help ensure patient safety, comfort, and proper access to surgical sites. Traditional disposable positioners are made from petroleum-based materials, which pose environmental hazards and lead to increased disposal costs. EcoSurg's innovative approach seeks to address these concerns by providing sustainable alternatives that reduce environmental impact while maintaining the necessary functionality for surgical procedures.

Cuff-Protect

Seed Round in 2013
Cuff-Mate skin barriers offer healthcare professionals a cost-effective way to protect their patients, themselves and equipment when taking vital signs.

Hubble Telemedical

Seed Round in 2013
Hubble Telemedical focuses on the early detection of systemic and debilitating diseases that can be identified through retinal examination. Their Telemedical Retinal Image Analysis and Diagnosis (TRIAD) technology offers real-time diagnosis of diabetic retinopathy and other retinal conditions, utilizing commonly available retina cameras. This innovative approach addresses the issue of many at-risk individuals not receiving necessary annual retinal exams due to accessibility and convenience challenges. By partnering with healthcare providers, insurance companies, and employers, Hubble Telemedical aims to make retinal screening more accessible, ultimately improving health outcomes and reducing healthcare costs. Their services are fully compliant with HIPAA regulations, ensuring security and ease of use. Clinical studies support the effectiveness of their technology in increasing annual screening compliance, thereby enhancing patient care and facilitating timely treatment for various diseases.

Hapten Sciences

Seed Round in 2013
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

SurgiLight

Seed Round in 2013
SurgiLight offers a surgical lighting system that provides surgeons with a practical illumination device, enabling them to focus on target areas.

Health & Bliss

Seed Round in 2013
Health & Bliss Inc. is a medical device company based in Memphis, Tennessee, specializing in the design, patenting, and sale of medical products and diagnostic tests. The company has developed Strep Test Anywhere, an innovative point-of-care device that enables testing for multiple infections, including strep throat, influenza A/B, chlamydia, gonorrhea, hepatitis B/C, and several other illnesses. By providing a means to obtain accurate test results without the need for a doctor visit, Health & Bliss aims to address significant barriers to effective healthcare, specifically time and cost. Their technology is designed to improve patient access to diagnostic services while benefiting healthcare providers and payers alike.

Mobilizer

Seed Round in 2013
Mobilizer Inc. has developed an innovative six-wheeled holster designed to facilitate medical ambulation for critical care patients. Modeled after a wheeled walker, this holster features shelves and attachments that allow healthcare providers to easily transport necessary medical equipment, thereby enhancing patient well-being and improving operational efficiency within hospitals. The company emerged from the ZeroTo510 medical device startup accelerator, focusing on solutions that streamline the process of moving patients while ensuring that essential tools are readily accessible.

AIS

Seed Round in 2013
Although it is still relatively new, AIS, having a relationship with other biology-inspired computing models, and computational biology.

Tidal Wave Technology

Seed Round in 2013
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Restore Medical Solutions

Series A in 2012
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Hubble Telemedical

Seed Round in 2012
Hubble Telemedical focuses on the early detection of systemic and debilitating diseases that can be identified through retinal examination. Their Telemedical Retinal Image Analysis and Diagnosis (TRIAD) technology offers real-time diagnosis of diabetic retinopathy and other retinal conditions, utilizing commonly available retina cameras. This innovative approach addresses the issue of many at-risk individuals not receiving necessary annual retinal exams due to accessibility and convenience challenges. By partnering with healthcare providers, insurance companies, and employers, Hubble Telemedical aims to make retinal screening more accessible, ultimately improving health outcomes and reducing healthcare costs. Their services are fully compliant with HIPAA regulations, ensuring security and ease of use. Clinical studies support the effectiveness of their technology in increasing annual screening compliance, thereby enhancing patient care and facilitating timely treatment for various diseases.

Urova Medical

Seed Round in 2012
Urova Medical was founded in Memphis, TN with the goal of providing a novel solution to cure stress urinary incontinence safely, effectively, and conveniently. Urova Medical’s technology was developed by an undergraduate team of talented biomedical engineers at Johns Hopkins University. The implant was designed extensively under the mentorship of physicians from the Johns Hopkins Hospital, the number one urological center in the US. Urova Medical has been part of the Zeroto510 Accelerator program sponsored by Innova Fund and MB Ventures, both venture capital firms based in Memphis

EcoSurg

Seed Round in 2012
EcoSurg is a developer of environmentally-friendly surgical supplies aimed at minimizing the carbon footprint in surgical settings. The company’s primary product, the EcoSurg line of patient positioners, consists of disposable foam shapes designed for use in over 20 million surgical procedures annually in the United States. These positioners help ensure patient safety, comfort, and proper access to surgical sites. Traditional disposable positioners are made from petroleum-based materials, which pose environmental hazards and lead to increased disposal costs. EcoSurg's innovative approach seeks to address these concerns by providing sustainable alternatives that reduce environmental impact while maintaining the necessary functionality for surgical procedures.

Nanophthalmics

Seed Round in 2012
Nanophthalmics has developed and is licensing a patent-pending platform technology for microfabricated instruments that engage tissue in entirely new ways. Their focus is on employing novel surgical devices, techniques, and materials to improve current treatment outcomes for ophthalmic and other microsurgical diseases. Their first commercial device is a disposable, 510(k) exempt, corneal micro-punch that enhances healing of abrasions, recurrent erosions, and other corneal diseases by modifying tissue attachments at a cellular level.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

BioNanovations

Seed Round in 2012
Bell BioNanonostics Corp. focuses on monitoring of bacterial infection. Bell BioNanonostics Corp. is based in the United States.

Urova Medical

Seed Round in 2012
Urova Medical was founded in Memphis, TN with the goal of providing a novel solution to cure stress urinary incontinence safely, effectively, and conveniently. Urova Medical’s technology was developed by an undergraduate team of talented biomedical engineers at Johns Hopkins University. The implant was designed extensively under the mentorship of physicians from the Johns Hopkins Hospital, the number one urological center in the US. Urova Medical has been part of the Zeroto510 Accelerator program sponsored by Innova Fund and MB Ventures, both venture capital firms based in Memphis

EcoSurg

Seed Round in 2012
EcoSurg is a developer of environmentally-friendly surgical supplies aimed at minimizing the carbon footprint in surgical settings. The company’s primary product, the EcoSurg line of patient positioners, consists of disposable foam shapes designed for use in over 20 million surgical procedures annually in the United States. These positioners help ensure patient safety, comfort, and proper access to surgical sites. Traditional disposable positioners are made from petroleum-based materials, which pose environmental hazards and lead to increased disposal costs. EcoSurg's innovative approach seeks to address these concerns by providing sustainable alternatives that reduce environmental impact while maintaining the necessary functionality for surgical procedures.

S2 Interactive

Seed Round in 2012
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.

Hubble Telemedical

Seed Round in 2012
Hubble Telemedical focuses on the early detection of systemic and debilitating diseases that can be identified through retinal examination. Their Telemedical Retinal Image Analysis and Diagnosis (TRIAD) technology offers real-time diagnosis of diabetic retinopathy and other retinal conditions, utilizing commonly available retina cameras. This innovative approach addresses the issue of many at-risk individuals not receiving necessary annual retinal exams due to accessibility and convenience challenges. By partnering with healthcare providers, insurance companies, and employers, Hubble Telemedical aims to make retinal screening more accessible, ultimately improving health outcomes and reducing healthcare costs. Their services are fully compliant with HIPAA regulations, ensuring security and ease of use. Clinical studies support the effectiveness of their technology in increasing annual screening compliance, thereby enhancing patient care and facilitating timely treatment for various diseases.

HandMinder

Seed Round in 2012
HandMinder is a developer of a portable hand rehabilitation device designed to aid stroke survivors in regaining hand function. With approximately 7 million stroke survivors in the United States and 795,000 new or recurrent cases each year, many face significant hand dysfunction, which affects their quality of life. Current rehabilitation methods primarily focus on muscle rehabilitation, often leaving patients in a passive role, and can be both expensive and inconvenient. Recognizing the need for more effective solutions, HandMinder utilizes patent-pending vibration-guided brain engagement technology that enhances neural connections between the hand and brain. Research indicates that this active engagement can double the amount of hand movement and improve its quality by 2.5 times compared to traditional treatments. The HandMinder device is designed to be affordable and convenient, making it suitable for use in both clinical settings and at home, ultimately aiming to improve rehabilitation outcomes for stroke victims.

Restore Medical Solutions

Seed Round in 2012
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.

Hapten Sciences

Seed Round in 2012
Hapten Sciences, Inc. operates as a biopharmaceutical company. It identifies and develops early-stage products, such as PDC-APB that acts as a vaccine to prevent contact dermatitis caused by exposure to urushiol oil in poison ivy, poison oak, or poison sumac plants. The company was incorporated in 2010 and is based in Memphis, Tennessee.

Veracity Medical

Seed Round in 2012
Veracity Medical Solutions, Inc. is a contract manufacturing company based in Collierville, Tennessee, specializing in the medical device industry. Founded in 2007, the company provides comprehensive manufacturing services, ranging from raw materials to finished products, including laser marking and packaging. Veracity Medical offers additional value-added services such as design, development, prototyping, and customization. The company employs a quality analysis system that ensures adherence to strict specifications, enabling clients to efficiently develop surgical instrumentation and implants. As of 2018, Veracity Medical operates as a subsidiary of Arcamed, LLC.

Tidal Wave Technology

Seed Round in 2012
Tidal Wave Technology manufactures a device to achieve a circumferential ablation of the nerves that surround the renal artery. It allows for renal denervation without placing any ablative elements within the renal artery. The company was founded in 2011 and is based in Memphis, Tennessee.

Protein Discovery

Series C in 2008
Protein Discovery, Inc. is a life sciences company specializing in the development and commercialization of innovative sample preparation technologies for protein and peptide analysis via mass spectrometry. The company offers several key products, including the Gelfree 8100 fractionation system, which separates complex protein mixtures into liquid-phase molecular weight fractions, and the Passport 1200 sample preparation system, designed to enrich low molecular weight proteins and peptides while eliminating matrix interferences, facilitating high-throughput quantification. Additionally, Protein Discovery provides the PPS Silent Surfactant, a reagent that solubilizes membrane proteins and reduces detergent interference. The UPX universal protein extraction kit is also available for detergent extraction of proteins from cells and tissues. Catering to life science researchers and drug development scientists, Protein Discovery markets its products both through Agilent Technologies and online, reaching a global audience. Founded in 2001 in Knoxville, Tennessee, the company was originally named Qgenics Biosciences, Inc. before rebranding to its current name in 2004.

Biomimetic Therapeutics

Series C in 2005
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.

Biomimetic Therapeutics

Series C in 2004
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.

GTx

Series E in 2003
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.

Biomimetic Therapeutics

Series B in 2003
BioMimetic Therapeutics is a biotechnology company focused on developing biologically active drug-device combination products that stimulate the body's natural tissue regenerative processes. Founded in 1999 and headquartered in Franklin, Tennessee, the company offers a range of products targeting various orthopedic and sports medicine conditions. These include Augment Injectable and Augment Rotator Cuff, which are designed for applications such as foot and ankle fusions, wrist fracture healing, and rotator cuff tear surgical treatment. Additionally, the Augment Tendinopathy Injection addresses injuries related to tendon overuse. Through its innovative approaches, BioMimetic Therapeutics aims to improve healing outcomes for patients with skeletal and associated tissue injuries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.